Concepedia

Publication | Open Access

Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats

23

Citations

86

References

2021

Year

Abstract

BT44 holds potential for further development into a novel, possibly disease-modifying, therapy for PD.

References

YearCitations

Page 1